Scientists at the Gladstone Institutes have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson’s. These findings, which stand in stark contrast to conventional wisdom, lay much-needed groundwork for developing treatments that target the disease’s elusive underlying mechanisms.
A Gladstone scientist wins the Nobel prize for discovering how to turn skin cells into stem cells capable of becoming heart, brain and other cell types.
Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.
Gladstone scientists have discovered environmental factors that critically influence the growth of a new type of stem cell.
Gladstone scientists participate in an international consortium that uses stem cell technology to tackle Huntington's disease
Gladstone Institutes Senior Investigator Shinya Yamanaka, MD, PhD, has won the Millennium Technology Award Grand Prize, the world's largest and most prominent technology award.
Scientists at the Gladstone Institutes have transformed skin cells into cells that develop into a neural network.
Scientists at the Gladstone Institutes today are announcing a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks—by converting scar-forming cardiac cells into beating heart muscle.
The American Association for the Advancement of Science (AAAS) has named Gladstone Senior Investigator Deepak Srivastava, MD, a Fellow for his efforts to advance science and its applications.